ProQR Therapeutics NV (PRQR)
3.64
+0.01
(+0.28%)
USD |
NASDAQ |
Nov 05, 14:44
ProQR Therapeutics Max Drawdown (5Y): 97.50% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 97.50% |
| September 30, 2024 | 97.50% |
| August 31, 2024 | 97.50% |
| July 31, 2024 | 97.50% |
| June 30, 2024 | 97.50% |
| May 31, 2024 | 97.50% |
| April 30, 2024 | 97.50% |
| March 31, 2024 | 97.50% |
| February 29, 2024 | 97.50% |
| January 31, 2024 | 97.50% |
| December 31, 2023 | 97.50% |
| November 30, 2023 | 97.50% |
| October 31, 2023 | 97.50% |
| September 30, 2023 | 97.50% |
| August 31, 2023 | 97.50% |
| July 31, 2023 | 97.50% |
| June 30, 2023 | 97.50% |
| May 31, 2023 | 97.50% |
| April 30, 2023 | 97.50% |
| March 31, 2023 | 97.50% |
| February 28, 2023 | 97.50% |
| January 31, 2023 | 97.50% |
| December 31, 2022 | 97.50% |
| November 30, 2022 | 97.50% |
| October 31, 2022 | 97.50% |
| Date | Value |
|---|---|
| September 30, 2022 | 97.50% |
| August 31, 2022 | 97.50% |
| July 31, 2022 | 97.50% |
| June 30, 2022 | 97.50% |
| May 31, 2022 | 97.50% |
| April 30, 2022 | 96.91% |
| March 31, 2022 | 96.00% |
| February 28, 2022 | 95.40% |
| January 31, 2022 | 88.80% |
| December 31, 2021 | 88.80% |
| November 30, 2021 | 88.80% |
| October 31, 2021 | 88.80% |
| September 30, 2021 | 88.80% |
| August 31, 2021 | 88.80% |
| July 31, 2021 | 88.80% |
| June 30, 2021 | 88.80% |
| May 31, 2021 | 88.80% |
| April 30, 2021 | 88.80% |
| March 31, 2021 | 88.80% |
| February 28, 2021 | 88.80% |
| January 31, 2021 | 88.80% |
| December 31, 2020 | 88.80% |
| November 30, 2020 | 88.80% |
| October 31, 2020 | 88.80% |
| September 30, 2020 | 88.80% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
88.80%
Minimum
Nov 2019
97.50%
Maximum
May 2022
93.51%
Average
97.20%
Median
Max Drawdown (5Y) Benchmarks
| uniQure NV | 94.93% |
| Merus NV | 67.42% |
| argenx SE | 38.20% |
| Pharming Group | -- |
| Pharvaris NV | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -18.12 |
| Beta (5Y) | 0.2568 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 101.5% |
| Historical Sharpe Ratio (5Y) | -0.1459 |
| Historical Sortino (5Y) | -0.2842 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 29.62% |